Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-27

Clinical Trial Update: The Effect of Intravenous Ketamine on Non Suicidal Self Injuries. [Phase 1, Phase 2]

View source ↗

Summary

A randomized or exploratory study investigating intravenous ketamine for non-suicidal self-injury across Phase 1 and Phase 2 stages, with currently unknown stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Non Suicidal Self Injury | Phase 1, Phase 2 | Status: UNKNOWN